WO2026009143 - CURABLE FORMULATIONS USABLE IN FORMING TRANSPARENT MATERIALS OR OBJECTS FEATURING HIGH MECHANICAL STRENGTH
National phase entry is expected:
Publication Number
WO/2026/009143
Publication Date
08.01.2026
International Application No.
PCT/IB2025/056660
International Filing Date
01.07.2025
Title **
[English]
CURABLE FORMULATIONS USABLE IN FORMING TRANSPARENT MATERIALS OR OBJECTS FEATURING HIGH MECHANICAL STRENGTH
[French]
FORMULATIONS DURCISSABLES UTILISABLES DANS LA FORMATION DE MATÉRIAUX OU D'OBJETS TRANSPARENTS PRÉSENTANT UNE RÉSISTANCE MÉCANIQUE ÉLEVÉE
Applicants **
STRATASYS, INC.
Inventors
DRIESSEN, Marcus Matheus
Priority Data
63/666,345
01.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3515 | |
| EPO | Filing, Examination, Granting | 28987 | |
| Japan | Filing, Examination, Granting | 3266 | |
| South Korea | Filing, Examination, Granting | 4335 | |
| USA | Filing, Examination, Granting | 14540 |
Total:
54,643
Contact Us
Abstract[English]
Curable formulations that provide, when hardened, transparent materials, and uses thereof, are provided. The curable formulations include two or more urethane (meth)acrylate materials which differ from one another at least by the number average molecular weight lower than 2000 grams/mol and/or the Tg, and optionally by the number of blocks and/or the NCO/OH ratio in the urethane (meth)acrylate material, and optionally a material or substance that is capable of interfering with the formation of micron-sized clusters in a hardened material formed of the formulations.[French]
L'invention concerne des formulations durcissables qui fournissent, lorsqu'elles sont durcies, des matériaux transparents, et leurs utilisations. Les formulations durcissables comprennent au moins deux matériaux de (méth)acrylate d'uréthane qui diffèrent l'un de l'autre au moins par le poids moléculaire moyen en nombre inférieur à 2000 grammes/mol et/ou la Tg, et éventuellement par le nombre de blocs et/ou le rapport NCO/OH dans le matériau de (méth)acrylate d'uréthane, et éventuellement un matériau ou une substance qui est capable d'interférer avec la formation d'agrégats de taille micrométrique dans un matériau durci formé des formulations.